Finance
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
Published by Global Banking and Finance Review
Posted on February 3, 2025
1 min readLast updated: January 26, 2026
Global Banking and Finance Review
Company
Published by Global Banking and Finance Review
Posted on February 3, 2025
1 min readLast updated: January 26, 2026
EssilorLuxottica's Nuance audio glasses, combining hearing aids with prescription lenses, received FDA approval and will launch in the U.S. and Italy in early 2025.
ROME (Reuters) - EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its over-the-counter Nuance audio glasses.
Nuance - which pairs hearing solutions with prescription glasses - will be available in the U.S. and in Italy in the first quarter of the year and in other European countries, including France, Germany and the UK, in the first half of 2025, a statement said.
"We didn't just combine two medical devices, we created entirely new smart glasses. It is not only groundbreaking, but also incredibly accessible. We're pleased now to turn our focus to getting this life-changing technology into the hands of people," Chairman and CEO Francesco Milleri said.
With Nuance the company aims to reach around 1.25 billion people worldwide who experience mild to moderate hearing loss, the statement added.
(Reporting by Giulia Segreti, editing by Gianluca Semeraro)
The article discusses EssilorLuxottica's FDA clearance for Nuance audio glasses, which combine hearing aids with prescription lenses.
Nuance glasses will be available in the U.S. and Italy in early 2025, with plans for other European countries by mid-2025.
The target market is approximately 1.25 billion people worldwide experiencing mild to moderate hearing loss.
Explore more articles in the Finance category
